【参考文献】
  1 Kamei M, Estafanous M, Lewis H.Tissue plasminogen activator in the treatment of vitreoretinal diseases. Semin Ophthalmol ,2000;15(1):44-50

2陶海,侯宝杰,吴海洋.微创玻璃体切割手术的现状.中华眼底病杂志,2004;20(3):200-201

3 Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin system. Thromb Haemost , 2005;93(4):647-654

4 Collen D, Lijnen, HR. Thrombolytic agents. Thromb Haemost , 2005;93(4):627-630

5 Siren V, Immonen I. uPA, tPA and PAI-1 mRNA expression in periretinal membranes. Curr Eye Res , 2003;27(5):261-267

6 Wileman SM, Booth NA, Moore N. Regulation of plasminogen activation by TGF-B in cultured human retinal endothelial cells. Br J Ophthalmol ,2000;84:417-472

7 Prager GW, Breuss JM, Steurer S. Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells. Blood , 2004;103(3):955-962

8 Le Gat L, Gogat K, Bouquet C, Saint-Geniez M, Darland D, Van Den Berghe L, Marchant D, Provost A, Perricaudet M. In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy. Gene Ther ,2003;10(25):2098-2103

9 Erem C, Hacihasanoglu A, Celik S, Ovali E, Ersoz HO, Ukinc K. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Princ Pract , 2005;14(1):22-30

10 Zhang X, Chaudhry A, Chintala SK. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol Vis ,2003;9:238-248

11 Kumada M, Niwa M, Hara A. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade. Invest Ophthalmol Vis Sci ,2005;46(4):1504-1507

12 O'Rourke J, Jiang X, Hao Z. Distribution of sympathetic tissue plasminogen activator (tPA) to a distant microvasculature. J Neurosci Res ,2005;79(6):727-733

13 Novokhatny VV, Jesmok GJ, Landskroner KA. Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis? Trends Pharmacol Sci ,2004;25(2):72-75

14 Marder VJ. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue-type plasminogen activator in the rabbit. Thromb Haemost ,2001;86:739-745

15 Stewart D. Distinct dose-dependent effects of plasmin and t-PA on coagulation and hemorrhage. Blood ,2003;101:3002-3007

16 Uemura A, Nakamura M, Kachi S. Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy. Arch Ophthalmol ,2005;123(2):209-213

17 Takano A, Hirata A, Inomata Y. Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous. Am J Ophthalmol ,2005;140(4):654-660

18 Kim NJ, Yu HG, Yu YS. Long-term effect of plasmin on the vitreolysis in rabbit eyes. Korean J Ophthalmol , 2004;18(1):35-40

19王庆平,徐格致.t-PA诱导猪玻璃体后脱离的实验研究.眼科研究,2003;21(2):130-139

20 Gandorfer A, Putz E, Welge-Lussen U. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol ,2001;85(1):6-10

上一页  [1] [2] [3] [4] [5] 下一页